GENINCODE PLC LS -01 (F:9PL) — Market Cap & Net Worth
Market Cap & Net Worth: GENINCODE PLC LS -01 (9PL)
GENINCODE PLC LS -01 (F:9PL) has a market capitalization of $6.36 Million (€5.44 Million) as of June 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #28082 globally and #2432 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GENINCODE PLC LS -01's stock price €0.01 by its total outstanding shares 725027042 (725.03 Million). Review 9PL current and long-term liabilities to assess the company's total debt and financial obligations.
GENINCODE PLC LS -01 Market Cap History: 2021 to 2026
GENINCODE PLC LS -01's market capitalization history from 2021 to 2026. Data shows change from $303.45 Million to $6.36 Million (-57.54% CAGR).
GENINCODE PLC LS -01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GENINCODE PLC LS -01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
13.49x
GENINCODE PLC LS -01's market cap is 13.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $303.45 Million | $1.15 Million | -$4.14 Million | 262.96x | N/A |
| 2022 | $68.66 Million | $1.43 Million | -$5.56 Million | 48.01x | N/A |
| 2023 | $48.32 Million | $2.16 Million | -$7.02 Million | 22.37x | N/A |
| 2024 | $36.45 Million | $2.70 Million | -$4.43 Million | 13.49x | N/A |
Competitor Companies of 9PL by Market Capitalization
Companies near GENINCODE PLC LS -01 in the global market cap rankings as of June 19, 2026.
Key companies related to GENINCODE PLC LS -01 by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #664 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #664 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
GENINCODE PLC LS -01 Historical Marketcap From 2021 to 2026
Between 2021 and today, GENINCODE PLC LS -01's market cap moved from $303.45 Million to $ 6.36 Million, with a yearly change of -57.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €6.36 Million | -60.53% |
| 2025 | €16.11 Million | -55.81% |
| 2024 | €36.45 Million | -24.56% |
| 2023 | €48.32 Million | -29.63% |
| 2022 | €68.66 Million | -77.37% |
| 2021 | €303.45 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of GENINCODE PLC LS -01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.36 Million USD |
| MoneyControl | $6.36 Million USD |
| MarketWatch | $6.36 Million USD |
| marketcap.company | $6.36 Million USD |
| Reuters | $6.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GENINCODE PLC LS -01
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology offers patients and physicians with preventative care and treatment strategies. The company's invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to prov… Read more